resorcinol has been researched along with Alzheimer Disease in 1 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nabuurs, RJ | 1 |
| Kapoerchan, VV | 1 |
| Metaxas, A | 1 |
| de Jongh, S | 1 |
| de Backer, M | 1 |
| Welling, MM | 1 |
| Jiskoot, W | 1 |
| Windhorst, AD | 1 |
| Overkleeft, HS | 1 |
| van Buchem, MA | 1 |
| Overhand, M | 1 |
| van der Weerd, L | 1 |
1 other study available for resorcinol and Alzheimer Disease
| Article | Year |
|---|---|
Polyfluorinated bis-styrylbenzenes as amyloid-β plaque binding ligands.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene; Binding, Competitive; Brain; Contrast Me | 2014 |